Gilead Sciences
GILD
#123
Rank
โ‚น14.005 T
Marketcap
โ‚น11,287
Share price
3.01%
Change (1 day)
43.97%
Change (1 year)

EPS for Gilead Sciences (GILD)

EPS in 2025 (TTM): โ‚น566.39

According to Gilead Sciences's latest financial reports the company's current EPS (TTM) is โ‚น589.16. In 2024 the company made an earnings per share (EPS) of โ‚น34.34 a decrease over its 2023 EPS that were of โ‚น411.15.

EPS history for Gilead Sciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น566.391549.48%
2024โ‚น34.34-91.65%
2023โ‚น411.1523.98%
2022โ‚น331.63-25.86%
2021โ‚น447.294850%
2020โ‚น9.04-97.64%
2019โ‚น383.130.9%
2018โ‚น379.7318.71%
2017โ‚น319.88-64.88%
2016โ‚น910.84-18.45%
2015โ‚น1,11755.28%
2014โ‚น719.28296.02%
2013โ‚น181.6317.89%
2012โ‚น154.07

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amgen
AMGN
โ‚น1,177 99.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚น1,295 119.79%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚น122.16-79.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚น403.92-31.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น993.07 68.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น155.42-73.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น943.32 60.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น1,854 214.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น686.19 16.47%๐Ÿ‡บ๐Ÿ‡ธ USA